Researchers at the Institut Pasteur in France have developed artificial “lymphoid organ-chips” that recreate much of the ...

Secondary lymphoid organs (SLOs) are the central organizing platform for the immune system's daily 'business': coping with infectious challenges from the environment. The following functional ...

New study shows that AI can predict lung cancer from digitized patient tissue samples rapidly and with a high degree of ...

Lymphoid proliferations are traditionally thought to be either benign conditions (reactive hyperplasia and lymphadenitis) or malignant lymphomas. However, not all lymphoid lesions at present can ...

Scientists believe the lymphoid organ-chip should be an asset in the face of a rapidly evolving SARS-CoV-2 pandemic.

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...

AtLP are conditions in which it is not possible to differentiate between the benign and the malignant nature of a given lymphoid infiltrate. The descriptive term AtLP may be used as an interim ...

The researchers concluded that oART, with BH technique, shows promise in reducing PTV margins and OAR doses in gastric ...

Dr El-Sharkawi's group researches chronic lymphocytic leukemia, rare leukaemias and lymphomas as well as early phase trials and drug development. Dima El-Sharkawi was appointed as a Consultant ...

In Type 1 diabetes (T1D), insulin-producing β-cells are killed by islet-infiltrating immune cells in a process called “insulitis”. T1D results in a critical requirement for exogenous insulin and ...

Adicet Bio (ACET) reported ADI-001 clinical biomarker data from the Phase 1 GLEAN trial which further reinforces the potential of ...